Literature DB >> 16510288

Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.

Julia Kaffy1, Renée Pontikis, Danièle Carrez, Alain Croisy, Claude Monneret, Jean-Claude Florent.   

Abstract

Novel combretastatin analogues bearing various five-membered heterocycles with consecutive oxygen and nitrogen atoms, in place of the olefinic bridge of CA4, have been synthesized (isoxazole, isoxazoline, oxadiazole, etc). These compounds have been evaluated for cytotoxicity and their ability to inhibit the tubulin assembly. On the basis of the relative position of the aromatic A- and B-rings on the heterocyclic moiety, they could be split in two classes, the alpha,gamma- or alpha,beta-diaryl heterocyclic derivatives. In the first series, the 3,5-diaryloxadiazole 9a displayed comparable antitubulin activity to that of CA4, but was devoid of cytotoxic effects. Among the alpha,beta-diaryl heterocyclic derivatives, the 4,5-diarylisoxazole 35 exhibited greater antitubulin activity than that of CA4 (0.75 vs 1.2 microM), but modest antiproliferative activity. These data showed that minor alteration in the chemical structure of the heterocyclic ring and its relative orientation with regard to the two phenyl rings of CA4 could dramatically influence the tubulin binding properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510288     DOI: 10.1016/j.bmc.2006.02.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  18 in total

1.  Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2011-12-21       Impact factor: 7.446

2.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Andrea Brancale; Ernest Hamel; Longchuan Chen; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

3.  Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues.

Authors:  Ganesh S Jedhe; Debasish Paul; Rajesh G Gonnade; Manas K Santra; Ernest Hamel; Tam Luong Nguyen; Gangadhar J Sanjayan
Journal:  Bioorg Med Chem Lett       Date:  2013-06-12       Impact factor: 2.823

4.  Diversity oriented synthesis and IKK inhibition of aminobenzimidazole tethered quinazoline-2,4-diones, thioxoquinazolin-4-ones, benzodiazepine-2,3,5-triones, isoxazoles and isoxazolines.

Authors:  Sureshbabu Dadiboyena; Aïcha Arfaoui; Hassen Amri; F Javier Piedrafita; Adel Nefzi
Journal:  Bioorg Med Chem Lett       Date:  2014-12-08       Impact factor: 2.823

5.  Solid Phase Synthesis of Isoxazole and Isoxazoline-carboxamides via [2+3]-Dipolar Cycloaddition Using Resin-bound Alkynes or Alkenes.

Authors:  Sureshbabu Dadiboyena; Adel Nefzi
Journal:  Tetrahedron Lett       Date:  2012-04-18       Impact factor: 2.415

6.  Regioselective One-Pot Synthesis, Biological Activity and Molecular Docking Studies of Novel Conjugates N-(p-Aryltriazolyl)-1,5-benzodiazepin-2-ones as Potent Antibacterial and Antifungal Agents.

Authors:  Asma Nsira; Hasan Mtiraoui; Sami Chniti; Hanan Al-Ghulikah; Rafik Gharbi; Moncef Msaddek
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

7.  Synthesis, biological evaluation, and modeling studies of 1,3-disubstituted cyclobutane-containing analogs of combretastatin A4.

Authors:  Andrii Malashchuk; Anton V Chernykh; Vasyl V Hurmach; Maxim O Platonov; Oleksandra Onopchenko; Sergey Zozulya; Constantin G Daniliuc; Alexey V Dobrydnev; Ivan S Kondratov; Yuriy S Moroz; Oleksandr O Grygorenko
Journal:  J Mol Struct       Date:  2020-05-10       Impact factor: 3.196

8.  Isoxazoles from 1,1-Disubstituted Bromoalkenes.

Authors:  Sureshbabu Dadiboyena; Jianping Xu; Ashton T Hamme
Journal:  Tetrahedron Lett       Date:  2007-02-12       Impact factor: 2.415

Review 9.  Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids.

Authors:  Prashant S Auti; Ginson George; Atish T Paul
Journal:  RSC Adv       Date:  2020-11-12       Impact factor: 4.036

10.  Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors.

Authors:  Sunil Kumar; Samir Mehndiratta; Kunal Nepali; Manish K Gupta; Surrinder Koul; Parduman R Sharma; Ajit K Saxena; Kanaya L Dhar
Journal:  Org Med Chem Lett       Date:  2013-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.